Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

被引:232
作者
Murai, M
Yoneyama, H
Ezaki, T
Suematsu, M
Terashima, Y
Harada, A
Hamada, H
Asakura, H
Ishikawa, H
Matsushima, K [1 ]
机构
[1] Univ Tokyo, Dept Mol Prevent Med, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan
[2] Niigata Univ, Dept Internal Med, Sch Med, Niigata 9518122, Japan
[3] Tokyo Womens Med Univ, Dept Anat & Dev Biol, Sch Med, Shinjyuku Ku, Tokyo 1628666, Japan
[4] Keio Univ, Dept Biochem, Sch Med, Shinjyuku Ku, Tokyo 1608582, Japan
[5] Keio Univ, Dept Microbiol, Sch Med, Shinjyuku Ku, Tokyo 1608582, Japan
基金
日本学术振兴会;
关键词
D O I
10.1038/ni879
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Acute graft-versus-host disease (a-GVHD) is initiated primarily by immunologically competent cytotoxic T cells (CTLs) that express anti-host specificities. However, the host lymphoid compartment in which these precursor CTLs are initially stimulated remains unclear. Here we show that gut Peyer's patches (PPs) are required to activate anti-host CTL responses in a well characterized murine acute graft-versus-host reaction (a-GVHR) model, involving transfer of parent lymphocytes into F1 hybrid recipients. The a-GVHR was prevented when recruitment of donor T cells into PP was interrupted either by disrupting the gene encoding chemokine receptor CCR5 or by blocking integrin alpha(4)beta(7)-MAdCAM- 1 (mucosal vascular addressin) interactions. Mice deficient for PPs failed to develop a-GVHD in two models of disease induction. Thus, blockade of CTL generation in PPs might offer new strategies for circumventing a-GVHD.
引用
收藏
页码:154 / 160
页数:7
相关论文
共 49 条
[1]   Acute graft-versus-host disease: inflammation run amok? [J].
Antin, JH .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (12) :1497-1498
[2]   Haematopoietic cell transplantation as immunotherapy [J].
Appelbaum, FR .
NATURE, 2001, 411 (6835) :385-389
[3]   The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice [J].
Baker, MB ;
Altman, NH ;
Podack, ER ;
Levy, RB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06) :2645-2656
[4]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[5]   Lymphocyte trafficking and regional immunity [J].
Butcher, EC ;
Williams, M ;
Youngman, K ;
Rott, L ;
Briskin, M .
ADVANCES IN IMMUNOLOGY, VOL. 72, 1999, 72 :209-253
[6]   Rapid acquisition of tissue-specific homing phenotypes by CD4+ T cells activated in cutaneous or mucosal lmphoid tissues [J].
Campbell, DJ ;
Butcher, EC .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) :135-141
[7]   Tumor necrosis factor-α production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease [J].
Cooke, KR ;
Hill, GR ;
Crawford, JM ;
Bungard, D ;
Brinson, YS ;
Delmonte, J ;
Ferrara, JLM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (10) :1882-1891
[8]   LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation [J].
Cooke, KR ;
Gerbitz, A ;
Crawford, JM ;
Teshima, T ;
Hill, GR ;
Tesolin, A ;
Rossignol, DP ;
Ferrara, JLM .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (12) :1581-1589
[9]   Minor antigen solves major problem [J].
Dazzi, F ;
Simpson, E ;
Goldman, JM .
NATURE MEDICINE, 2001, 7 (07) :769-770
[10]   A QUICK AND SIMPLE METHOD FOR THE QUANTITATION OF LACTATE-DEHYDROGENASE RELEASE IN MEASUREMENTS OF CELLULAR CYTO-TOXICITY AND TUMOR NECROSIS FACTOR (TNF) ACTIVITY [J].
DECKER, T ;
LOHMANNMATTHES, ML .
JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 115 (01) :61-69